Chantal management ouster sought by shareholder group; Mosbacher asked to take helm.
This article was originally published in The Rose Sheet
CHANTAL TERMINATING STANSON MARKETING DISTRIBUTION DEAL under an agreement in principle reached by the two companies, Chantal Pharmaceuticals said. Under the agreement, Stanson will receive 1.2 mil. shares of Chantal common stock and retain a limited right to sell off a portion of its inventory of Chantal's Ethocyn skin care products, returning the balance to Los Angeles-based Chantal.
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review